The aim of this study was to prospectively investigate whether Prx4 is independently associated with cardiovascular and all-cause mortality and whether it could potentially be a new cardiovascular biomarker in patients with T2DM. The gene discussed is PRDX4; the disease is type 2 diabetes mellitus.